Literature DB >> 2734109

Nucleotide sequence of an intronless gene for a human arylamine N-acetyltransferase related to polymorphic drug acetylation.

D M Grant1, M Blum, A Demierre, U A Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2734109      PMCID： PMC317878          DOI： 10.1093/nar/17.10.3978

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver.

Authors:  D M Grant; F Lottspeich; U A Meyer
Journal:  FEBS Lett       Date:  1989-02-13       Impact factor: 4.124

2.  Arylamine N-acetyltransferase from chicken liver II. Cloning of cDNA and expression in Chinese hamster ovary cells.

Authors:  S Ohsako; M Ohtomi; Y Sakamoto; K Uyemura; T Deguchi
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

Review 3.  N-acetylation pharmacogenetics.

Authors:  W W Weber; D W Hein
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468
  3 in total
  10 in total

1.  Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

Authors:  D M Grant; K Mörike; M Eichelbaum; U A Meyer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.

Authors:  I Cascorbi; N Drakoulis; J Brockmöller; A Maurer; K Sperling; I Roots
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

3.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Authors:  M Blum; A Demierre; D M Grant; M Heim; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.

Authors:  M Blum; D M Grant; A Demierre; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors:  I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal:  Clin Investig       Date:  1992 Mar-Apr

Review 6.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

7.  Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).

Authors:  Neville J Butcher; Ajanthy Arulpragasam; Catherine Pope; Rodney F Minchin
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

8.  A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology.

Authors:  Timothy L Lash; Brian D Bradbury; Jemma B Wilk; Ann Aschengrau
Journal:  Breast Cancer Res       Date:  2005-03-21       Impact factor: 6.466

Review 9.  N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes.

Authors:  M Watanabe; T Igarashi; T Kaminuma; T Sofuni; T Nohmi
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

10.  Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.

Authors:  Samantha M Carlisle; David W Hein
Journal:  Int J Oncol       Date:  2018-06-11       Impact factor: 5.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.